Literature DB >> 3400633

Precipitation of dialysis dementia by deferoxamine treatment of aluminum-related bone disease.

D J Sherrard1, J V Walker, J L Boykin.   

Abstract

Five patients with chronic renal failure, complicated by bone aluminum toxicity, were treated with deferoxamine (DFO). This treatment appeared to precipitate dialysis dementia, which was fatal in three patients. In two patients, continuous treatment with lower doses of DFO was possible. The development of dialysis dementia in chronic renal failure patients with very high serum aluminum levels may be a complication of DFO treatment.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3400633     DOI: 10.1016/s0272-6386(88)80007-6

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  7 in total

Review 1.  Nephrology, dialysis and transplantation.

Authors:  K Farrington; P Sweny
Journal:  Postgrad Med J       Date:  1990-07       Impact factor: 2.401

Review 2.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

Review 3.  The role of chelation in the treatment of other metal poisonings.

Authors:  Silas W Smith
Journal:  J Med Toxicol       Date:  2013-12

4.  ACMT Recommends Against Use of Post-Chelator Challenge Urinary Metal Testing.

Authors: 
Journal:  J Med Toxicol       Date:  2017-07-19

Review 5.  The neurotoxicity of environmental aluminum is still an issue.

Authors:  Stephen C Bondy
Journal:  Neurotoxicology       Date:  2010-05-27       Impact factor: 4.294

Review 6.  The biological speciation and toxicokinetics of aluminum.

Authors:  E DeVoto; R A Yokel
Journal:  Environ Health Perspect       Date:  1994-11       Impact factor: 9.031

7.  Aluminum Intoxication in Chronic Kidney Disease.

Authors:  Rodrigo Bueno de Oliveira; Fellype Carvalho Barreto; Lucas Acatauassu Nunes; Melani Ribeiro Custódio
Journal:  J Bras Nefrol       Date:  2021-12-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.